Committee on Assessing the Need for Clinical Trials of Testosterone Replacement Therapy, Board on Health Sciences Policy ; Catharyn T. Liverman and Dan G. Blazer, editors.
INTRODUCTION -- Scope of this Report -- Aging and Hormonal Changes -- Testosterone, Human Development, and Health -- Measuring Testosterone Levels -- Testosterone Therapy -- Growing Use of Testosterone Therapy -- Clinical Trials -- TESTOSTERONE AND HEALTH OUTCOMES -- Changes in Endogenous Testosterone Levels with Aging -- Literature Review -- Bone -- Body Composition and Strength -- Physical Function -- Cognitive Function -- Mood and Depression -- Sexual Function -- Health-Related Quality of Life -- Cardiovascular and Hematologic Outcomes -- Prostate Outcomes -- Other Health Outcomes -- Multiple Outcomes -- FUTURE RESEARCH DIRECTIONS -- Strategy for Future Clinical Trials in Older Men -- Recommendations -- Initial Efficacy Trials in Older Men -- Protection of Research Participants: Safety and Ethical Issues -- Additional Areas of Research -- Need for Efficacy Studies in Older Men -- Clinical Studies in Middle-Aged Men.
0
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
Testosterone and aging.
0309090636
Aging-- Prevention.
Longevity.
Testosterone-- Physiological effect.
Aged.
Aging-- drug effects.
Testosterone-- physiology.
Testosterone-- therapeutic use.
Aging-- Prevention.
Longevity.
MEDICAL-- Reproductive Medicine & Technology.
Testosterone-- Physiological effect.
MED-- 082000
612
.
6/8
22
RA776
.
75
.
T45
2004eb
WT
104
T3455
2004
Blazer, Dan G.,II, (Dan German),1944-
Liverman, Catharyn T.
National Research Council (U.S.)., Committee on Assessing the Need for Clinical Trials of Testosterone Replacement Therapy.